Torliptin VM 500

Torliptin VM 500 contains Vildagliptin, a member of the islet enhancer class, is a potent and selective DPP-4 inhibitor and Metformin, a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose.

Dosage Form

Tablet

Route of Administration

Oral

Composition

Each film-coated tablet contains:

Vildagliptin I.P. 50 mg
Metformin Hydrochloride I.P. 500 mg
Excipients q.s.

Indications

Indicated for the treatment of type II diabetes mellitus when diet, exercise, and treatment with a single antidiabetic agent do not provide adequate glycemic control.

Storage

Store protected from moisture at a temperature not exceeding 30°C.

Precautions

Avoid use in patients with severe renal impairment, acute metabolic acidosis, diabetic ketoacidosis, diabetic pre-coma, hepatic impairment, acute alcohol intoxication, or conditions causing dehydration, severe infection, shock, or tissue hypoxia. Use with caution with NSAIDs, ACE inhibitors, angiotensin II receptor antagonists, and diuretics, and monitor for hypoglycemia and signs of lactic acidosis.

Presentation

10 x 15 Tablets

GLOBAL HORIZONS

Your Efforts Extended Through a Partnership That's Better Together

Become a Dealer